Source:http://linkedlifedata.com/resource/pubmed/id/10986064
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
18
|
pubmed:dateCreated |
2000-10-6
|
pubmed:abstractText |
Cost-utility analyses (CUAs) present the value of an intervention as the ratio of its incremental cost divided by its incremental survival benefit, with survival weighted by utilities to produce quality-adjusted life years (QALYs). We critically reviewed the CUA literature and its role in informing clinical oncology practice, research priorities, and policy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0732-183X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3302-17
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10986064-Clinical Trials as Topic,
pubmed-meshheading:10986064-Cost-Benefit Analysis,
pubmed-meshheading:10986064-Health Care Costs,
pubmed-meshheading:10986064-Humans,
pubmed-meshheading:10986064-Medical Oncology,
pubmed-meshheading:10986064-Neoplasms,
pubmed-meshheading:10986064-Publications
|
pubmed:year |
2000
|
pubmed:articleTitle |
Systematic overview of cost-utility assessments in oncology.
|
pubmed:affiliation |
Center for Outcomes and Policy Research, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. craig_earle@dfci.harvard.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|